Loading organizations...
Loading organizations...
| Date | Company | Round | Lead Investor(s) | Co-Investor(s) |
|---|---|---|---|---|
| Sep 23, 2025 | Ensoma | $53.0M Other Equity | — | 5AM Ventures, Bill & Melinda Gates Foundation, Catalio Capital Management, Cormorant Asset Management, Delos Capital, F-Prime Capital, Gilead Sciences, Mirae Asset, Qatar Investment Authority, RTW Investments, Solasta Ventures, SymBiosis, Viking Global Investors |
| Oct 1, 2022 | Cellarity | $120.0M Series C | — | Flagship Pioneering, Kyowa Kirin |
| Apr 1, 2022 | Tessera Therapeutics | $300.0M Series C | — | Catalio Capital, Flagship Ventures, Petri, Abu Dhabi Investment Authority, Alaska Permanent Fund, Altitude Life Science Ventures, Cormorant Asset Management, Longevity Vision Fund, March Capital, SALT Fund, Vali Barsan, T. Rowe Price Associates |
| Sep 30, 2021 | Catalog | $35.0M Series B | Nick Ha | Horizons Ventures |